An allergist, dermatologist, and OB-GYN explain how progesterone dermatitis presents and which treatments can help you ease ...

Approval of the topical aryl hydrocarbon receptor agonist was supported by the pivotal ADORING studies. In the ...

KKH and the National Skin Centre say there are more such patients, but no recent studies have been done. Read more at ...

In a subset of patients in a 48-week extension trial, the mean duration of the first treatment-free interval was ...

The prevalence of eczema in Singapore has been largely stable in the past decade, affecting about one in five children and ...

A new study finds that that eczema can worsen when air quality drops from good to moderate levels on the Environmental ...

Parents of children with eczema are more likely to be short on sleep and to use medication to try to get more of it, a ...

AnaptysBio is dropping its atopic dermatitis (AD) drug candidate after the compound failed to reduce eczema area and itch ...

When 30-year-old Eve (not her real name) gave birth to her baby son, Luke (not his real name), in early 2024, she knew she ...

The US FDA has approved Galderma's Nemluvio (nemolizumab), for individuals aged 12 years and above with moderate-to-severe atopic dermatitis.

The FDA has blessed two previously approved medicines—one a cream and the other an injection—to treat atopic dermatitis (AD).

Luckily, there are options that specifically target eczema flare-ups and alleviate the symptoms, including shampoos that are ...